Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Classical and Bayesian Inference of Conditional Stress-Strength Model under Kumaraswamy Distribution. | Comput Intell Neurosci | 2021 | 34373685 | PubTator, text mining | PubMed |
| PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib. | Front Oncol | 2021 | 34367968 | PubTator, text mining | PubMed |
| Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers. | Front Oncol | 2021 | 34367942 | PubTator, text mining | PubMed |
| Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder. | Front Genet | 2021 | 34367251 | PubTator, text mining | PubMed |
| MicroRNA and Other Non-Coding RNAs in Epstein-Barr Virus-Associated Cancers. | Cancers (Basel) | 2021 | 34359809 | PubTator, text mining | PubMed |
| Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 34359727 | PubTator, text mining | PubMed |
| Gatekeepers of the Gut: The Roles of Proteasomes at the Gastrointestinal Barrier. | Biomolecules | 2021 | 34356615 | PubTator, text mining | PubMed |
| Association of Immune and Inflammatory Gene Polymorphism With the Risk of IgA Nephropathy: A Systematic Review and Meta-Analysis of 45 Studies. | Front Immunol | 2021 | 34354705 | PubTator, text mining | PubMed |
| Deregulation of HLA-I in cancer and its central importance for immunotherapy. | J Immunother Cancer | 2021 | 34353849 | PubTator, text mining | PubMed |
| Differentially Expressed Gene Pathways in the Conjunctiva of Sjögren Syndrome Keratoconjunctivitis Sicca. | Front Immunol | 2021 | 34349764 | PubTator, text mining | PubMed |
| Overview of virus and cancer relationships. Position paper. | Rev Esp Quimioter | 2021 | 34348449 | PubTator, text mining | PubMed |
| Expansion of Unique Hepatitis C Virus-Specific Public CD8+ T Cell Clonotypes during Acute Infection and Reinfection. | J Immunol | 2021 | 34341170 | PubTator, text mining | PubMed |
| The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer. | Front Oncol | 2021 | 34336649 | PubTator, text mining | PubMed |
| SUMOylated non-canonical polycomb PRC1.6 complex as a prerequisite for recruitment of transcription factor RBPJ. | Epigenetics Chromatin | 2021 | 34332624 | PubTator, text mining | PubMed |
| A review on the advances and challenges of immunotherapy for head and neck cancer. | Cancer Cell Int | 2021 | 34332576 | PubTator, text mining | PubMed |
| CD8+ T Cells Involved in Metabolic Inflammation in Visceral Adipose Tissue and Liver of Transgenic Pigs. | Front Immunol | 2021 | 34322121 | PubTator, text mining | PubMed |
| Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. | Cancer Res | 2021 | 34321242 | PubTator, text mining | PubMed |
| Flavan-3-ol Microbial Metabolites Modulate Proteolysis in Neuronal Cells Reducing Amyloid-beta (1-42) Levels. | Mol Nutr Food Res | 2021 | 34318994 | PubTator, text mining | PubMed |
| Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial. | J Clin Oncol | 2021 | 34310172 | PubTator, text mining | PubMed |
| Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma. | Cancer Sci | 2021 | 34309966 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=55